Halozyme Therapeutics Stock Price (NASDAQ:HALO)

Add to My Stocks
$12.41 $0.19 (1.51%) HALO stock closing price May 26, 2017 (Closing)
Halozyme Therapeutics
26 MAY 2017
amigobulls logo
HALO hand_up
HALO vs S&P 500
Closing Price: May 26, 2017
$12.41 ( -1.51%)
S&P 500
2415.8 ( 0.03%)
52 Week Price Range
1 Year Return: 27.4%
Q1 Growth*
Profitable ?
net image
2017 Q1 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Halozyme Therapeutics Snapshot Video

14 5 2

HALO Stock Details

Prev Close* : $12.60
Market Cap:
Day Low: $12.36
52 Week Low: $7.70
Open: $12.52
Volume: 671809
Day High: $12.64
52 Week High: $15.20

Latest Stock Market News

Latest Articles

Halozyme Therapeutics News - From Partners

Company News for January 06, 2017   by Zacks on Jan 06, 2017

HALO Stockcharts

View HALO PE ratio, PS ratio stocks charts and compare with peers.
HALO Chart
Note: Compare Halozyme Therapeutics stock price history with the index and industry peers.

Halozyme Therapeutics Valuation

PS ratio (
price to sales ratio

Halozyme Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover

HALO Industry Peers

Company Price Change (%)
Kythera Biopharma (KYTH)74.980 (0%)
Sarepta Therapeutics (SRPT)30.010.84 (2.72%)
Pfizer (PFE)32.140.02 (0.06%)
Abbvie (ABBV)66.060.26 (0.39%)
Eli Lilly (LLY)78.050.29 (0.37%)
Baxalta (BXLT)46.020.18 (0.39%)
Johnson & Johnson (JNJ)126.920.61 (0.48%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)2.40.2 (9.09%)
MannKind (MNKD)1.520.1 (7.04%)
Emergent Biosolutions (EBS)32.111.91 (6.32%)
Sorrento Therapeutics (SRNE)1.750.1 (6.06%)
OncoMed Pharma (OMED)3.680.16 (4.55%)
Sinovac Biotech (SVA)5.260.21 (4.16%)
Genomic Health (GHDX)30.611.12 (3.8%)
Top gainers from Medical-Biomed-Genetics industry
* As of May 26, 2017
CompanyPriceChange (%)
Lion Biotech (LBIO)5.650.5 (8.13%)
Geron (GERN)2.770.24 (7.97%)
ALBIREO PHARMA (ALBO)19.141.63 (7.85%)
Sangamo BioSciences (SGMO)7.250.55 (7.05%)
Insmed (INSM)16.071.07 (6.24%)
NewLink Genetics (NLNK)14.340.9 (5.91%)
Prothena (PRTA)51.882.97 (5.41%)
Top losers from Medical-Biomed-Genetics industry
* As of May 26, 2017

Halozyme Therapeutics, Inc. Stock News - Partner Headlines

Halozyme Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues146.69M135.05M75.33M54.79M42.32M
Net Income-103.02M-32.23M-68.37M-83.47M-53.55M
Total Operating Expense196.69M133.25M115.63M128.97M94.85M
view Halozyme Therapeutics, Inc. income statement
balance sheet20162015201420132012
Total Assets261.51M181.78M165.97M101.79M134.72M
Total Liabilities293.99M138.79M124.62M121.78M85.87M
Shareholders Equity-32.48M42.99M41.35M-19.99M48.85M
view Halozyme Therapeutics, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities8M-29.49M0.1M22.1M-20.22M
Net Cash From (Used By) Operating Activities-50.38M-37.08M-47.51M-49.33M-64.32M
Increase (Decrease) In Prop Plant And Equipment-3.13M-2.36M-1.36M-2.29M-1.41M
view Halozyme Therapeutics, Inc. cashflow statement

Halozyme Therapeutics Stock Message Board

Halozyme Therapeutics stock lost -1.87 %, and the last close price as of 25 May, 2017 is 12.6 for HALO stock. Stock price or share price can be used to find the total market value of a company. Halozyme Therapeutics market cap stands at 1.8B as of 25 May, 2017. Halozyme Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Halozyme Therapeutics is worth a lot, it will most likely be reflected in an inflated Halozyme Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 874284 on the last trading day, as is evident from Halozyme Therapeutics stock chart, and HALO stock quote data. To check the historical stock price movement, all time high, and all time low of HALO, view Halozyme Therapeutics stock price history.